Sarwar Islam is now serving in a new position at Concordia International Corp.
Sep 14, 2017 - RelSci Data Update
Board and Executive Moves

Background Information:
Chief Corporate Development Officer at Concordia International Corp.
Career:
In The News:
Concordia International Corp. Announces Second Quarter 2017 Results
August 11, 2017  •  PR Newswire
-Cancer survival prediction tool developed by University of Leicester researchers
July 21, 2017  •  ENP Newswire
Chief Corporate Development Officer at Concordia International Corp.
Concordia International Corp. is an integrated, specialty healthcare company that focuses on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population. It engages in the development of pharmaceutical products and medical devices. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in Oakville, Canada.
In The News:
Morning Alert: Concordia International hits 52-week low sixth time in one month 28 April 2017 12:13 EDT
April 28, 2017  •  News Bites Canadian Markets
Edward J. Borkowski is no longer serving in their position at Concordia International Corp.
April 27, 2017  •  RelSci
Concordia International Appoints David Price as Chief Financial Officer
April 27, 2017  •  News Bites Canadian Markets
Concordia International Corp. is an integrated, specialty healthcare company that focuses on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population. It engages in the development of pharmaceutical products and medical devices. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in Oakville, Canada.